Ebitda تغيير تاريخ
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
ALKERMES USD 80.26M 20.05M 2026-03
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.14B 775M 2025-12
Baxter International USD -447M 873M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cipla INR 9.55B 3B 2026-03
Dr.Reddys Laboratories INR 6.46B 14.43B 2026-03
Eisai JPY -335M 30.43B 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Exelixis USD 258.29M 15.43M 2026-03
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Incyte USD 367.97M 46.53M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
Merck USD 6.3B 2.09B 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 5.3B 530M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Takeda JPY 150.25B 297.88B 2026-03
Teva Pharmaceutical Industries USD 1.06B 582M 2026-03
Xencor USD -51.05M 55.28M 2025-12